XML 64 R69.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation - Non-option Instruments (Details) (USD $)
In Millions, except Share data, unless otherwise specified
 12 Months Ended
Jun. 01, 2013
Jun. 02, 2012
May 28, 2011
May 29, 2010
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]        
Granted, Shares (300,000)      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition 1 year 5 months 27 days      
Performance share units [Member]
        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Total Intrinsic Value $ 2.0 $ 0 $ 0 $ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]        
Outstanding, at beginning of year, Shares 0 90,380 178,862  
Granted, Shares 72,500 0 0  
Vested, Shares 0 (90,380) (88,482)  
Outstanding, at end of year, Shares 72,500 0 90,380 178,862
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Outstanding, at beginning of year, Weighted Average Remaining Contractual Term (in years) 2 years 1 month 6 days 0 years 2 months 12 days 8 months 12 days
Outstanding, at end of year, Weighted Average Remaining Contractual Term (in years) 2 years 1 month 6 days 0 years 2 months 12 days 8 months 12 days
Ending vested and expected to vest, Shares 68,823 0 0  
Ending vested and expected to vest, Aggregrate Intrinsic Value (in dollars) $ 1.9 $ 0 $ 0  
Ending vested and expected to vest, Weighted Average Remaining Contractual Term (in years) 2 years 1 month 6 days 0 years 0 years  
Restricted stock grants [Member]
        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]        
Outstanding, at beginning of year, Shares 83,331 70,595 54,729  
Granted, Shares 0 24,323 33,000  
Vested, Shares (14,357) (7,787) (15,041)  
Forfeited or expired, Shares (1,500) (3,800) (2,093)  
Outstanding, at end of year, Shares 67,474 83,331 70,595  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Outstanding, at beginning of year, Weighted Average Grant-Date Fair Value (in dollars per share) $ 19.49 $ 18.44 $ 19.48  
Granted, Weighted Average Granted-Date Fair Value (in dollars per share) $ 0 $ 21.46 $ 20.63  
Vested, Weighted Average Grant-Date Fair Value (in dollars per share) $ 15.06 $ 17.56 $ 26.79  
Forfeited or expired, Weighted Average Grant-Date Fair Value (in dollars per share) $ 18.71 $ 16.44 $ 20.26  
Outstanding, at end of year, Weighted Average Grant-Date Fair Value (in dollars per share) $ 20.45 $ 19.49 $ 18.44  
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition 2 years 6 months      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value 0.3      
Restricted stock units [Member]
        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]        
Outstanding, at beginning of year, Shares 321,723 285,101 214,406  
Granted, Shares 341,534 125,589 140,357  
Forfeited or expired, Shares (66,368) (10,483) (4,704)  
Released, Shares (17,569) (78,484) (64,958)  
Outstanding, at end of year, Shares 579,320 321,723 285,101 214,406
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]        
Outstanding, at end of year (in dollars) $ 16.0 $ 5.7 $ 6.9 $ 4.0
Outstanding, at beginning of year, Weighted Average Remaining Contractual Term (in years) 1 year 8 months 12 days 1 year 4 months 24 days 1 year 6 months 1 year 2 months 12 days
Outstanding, at end of year, Weighted Average Remaining Contractual Term (in years) 1 year 8 months 12 days 1 year 4 months 24 days 1 year 6 months 1 year 2 months 12 days
Ending vested and expected to vest, Shares 547,093 308,645 269,679  
Ending vested and expected to vest, Aggregrate Intrinsic Value (in dollars) $ 15.0 $ 5.4 $ 6.6  
Ending vested and expected to vest, Weighted Average Remaining Contractual Term (in years) 1 year 7 months 6 days 1 year 4 months 24 days 1 year 6 months